Duchesnay is a specialty pharmaceutical company with a long-standing commitment to women’s health

Safeguarding the health of pregnant women and their babies

Duchesnay works to continuously advance maternal-fetal medicine and scientific knowledge to help women enjoy a healthy and joyful pregnancy, while reducing the risk of birth defects in their babies.

Ensuring women’s health at every stage of life

Duchesnay’s commitment to women’s health goes far beyond pregnancy and breastfeeding. That’s why we have broadened our portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives.

 

Straight facts about Diclectin®

Of all medications indicated for use in pregnancy, Diclectin is the most studied in the world in terms of safety and efficacy. It is the only prescription medication approved by Health Canada specifically indicated to treat nausea and vomiting of pregnancy (NVP).

Diclectin® has been prescribed for over 40 years in Canada and has been proven safe and effective for use throughout pregnancy. It is a specially formulated combination of doxylamine succinate (an antihistamine) and pyridoxine hydrochloride (vitamin B6) and has been used by over 35 million women worldwide to treat NVP.

As recently as 2016, a Health Canada Scientific Advisory Panel and ...

 

Read More >

Duchesnay Expands its Women’s Health Product Portfolio with Acquisition of Osphena® from Shionogi Inc.
Duchesnay Inc. is pleased to announce that Health Canada has granted market authorization for Mictoryl®/Mictoryl® Pediatric
Duchesnay Summarizes Comprehensive Body of Evidence for Most Studied Morning Sickness Drug Worldwide – Over 40 years of clinical experience, 16 cohort studies, two meta-analyses support regulatory approvals and guidelines –